Company Filing History:
4 out of 118 
3 out of 3,539 
1 out of 1,035 
Years Active: 2014-2017
Title: Innovations and Contributions of Petr Illarionov
Introduction
Petr Illarionov is a notable inventor based in Birmingham, GB, recognized for his significant contributions to the field of medical research. He holds a total of four patents, showcasing his innovative approach to treating and preventing inflammatory diseases.
Latest Patents
Illarionov's latest patents include groundbreaking methods for the treatment and prevention of inflammatory diseases. His research demonstrates that treatment of young, suckling mice with a glycolipid activates NKT cells in a CD1d-restricted manner, providing protection against airway hyperreactivity in models of allergen-induced asthma. Furthermore, he found that this protective effect can be transferred by NKT cells exposed to the glycolipid, which is associated with the expansion of suppressive double-negative NKT cells and Foxp3 T cells. Additionally, his work on beta-mannosylceramide highlights its potential as a Type I NKT cell agonist, which can be used in conjunction with other therapeutic agents to enhance anti-tumor immunity.
Career Highlights
Throughout his career, Illarionov has worked with prestigious institutions such as the University of Birmingham and the National Institutes of Health, a component of the US Department of Health & Human Services. His research has significantly advanced the understanding of immune responses and therapeutic strategies for inflammatory diseases.
Collaborations
Illarionov has collaborated with esteemed colleagues, including Jay A Berzofsky and Jessica J O'Konek, contributing to the advancement of knowledge in his field.
Conclusion
Petr Illarionov's innovative research and patents have made a substantial impact on the treatment of inflammatory diseases, showcasing his dedication to advancing medical science. His work continues to inspire future research and development in this critical area.